Literature DB >> 8985040

A phase I and II clinical trial of a newly developed ultrasound hyperthermia system with an improved planar transducer.

M Mitsumori1, M Hiraoka, Y Okuno, Y Nishimura, Y P Li, S Fujishiro, Y Nagata, M Abe, M Koishi, T Sano, T Marume, N Takayama.   

Abstract

PURPOSE: The clinical usefulness of a newly developed ultrasound hyperthermia system was evaluated. METHODS AND MATERIALS: The hyperthermia system uses a modified planer transducer operated at frequencies of 0.5, 1.0, and 1.5 MHz. The transducer has a nonvibrating part at the center to reduce the central hot spot. Frequency sweeping technique is also used to eliminate the annular hot spot around the center. Thirty-eight tumors in 29 patients were examined in this study. In 35 tumors, hyperthermia was given in conjunction with irradiation and/or chemotherapy, and in the remaining 3 tumors, hyperthermia alone was given. In all, a total of 153 hyperthermia sessions were performed.
RESULTS: The number of hyperthermia sessions per tumor ranged from 1 to 7 (mean, 4.0 +/- 1.3). The number of intratumor thermometry points per session ranged from 1 to 8 (mean, 4.3 +/- 1.5). The average intratumor temperature for tumors with a maximum depth of <3 cm, 3-6 cm, and >6 cm was 42.1 +/- 1.2, 41.7 +/- 1.4, and 39.9 +/- 2.0 degrees C, respectively. The percentage of monitored intratumor points with temperature exceeding 42 degrees C was 56 +/- 31%, 43 +/- 34%, and 21 +/- 24%, respectively. Of the 30 evaluable tumors treated with combined irradiation, 12 showed complete response, 14 partial response, and 4 no change. Observed complications included pain at the treatment site in 13 of the 153 treatment sessions and vesicle formation in 3 of the 38 treatment sites. No serious complication was seen.
CONCLUSIONS: These results indicate that the newly developed ultrasound hyperthermia system is clinically useful for the treatment of localized superficial and subsurface tumors with a maximum tumor depth of no more than 6 cm.

Entities:  

Mesh:

Year:  1996        PMID: 8985040     DOI: 10.1016/s0360-3016(96)00363-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  1 in total

Review 1.  Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment.

Authors:  André C Silva; Tiago R Oliveira; Javier B Mamani; Suzana M F Malheiros; Luciana Malavolta; Lorena F Pavon; Tatiana T Sibov; Edson Amaro; Alberto Tannús; Edson L G Vidoto; Mateus J Martins; Ricardo S Santos; Lionel F Gamarra
Journal:  Int J Nanomedicine       Date:  2011-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.